SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001493152-24-049097
Filing Date
2024-12-06
Accepted
2024-12-09 08:30:22
Documents
4
Period of Report
2024-12-06

Document Format Files

Seq Description Document Type Size
1 formdef14a.htm DEF 14A 732846
2 formdef14a_001.jpg GRAPHIC 19351
3 proxy_001.jpg GRAPHIC 460113
4 proxy_002.jpg GRAPHIC 441046
  Complete submission text file 0001493152-24-049097.txt   2002102
Mailing Address 4851 TAMIAMI TRAIL NORTH SUITE 200 NAPLES FL 34103
Business Address 4851 TAMIAMI TRAIL NORTH SUITE 200 NAPLES FL 34103 (646) 491 9132
CONDUIT PHARMACEUTICALS INC. (Filer) CIK: 0001896212 (see all company filings)

IRS No.: 873272543 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-41245 | Film No.: 241533932
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)